ÌÇÐÄÖ±²¥

dr. MJ (Maiwenn) Al

Biography

Maiwenn Al obtained her Master degree in Mathematics at Leiden University in 1991. Since 1992 she has been working at the institute for Medical Technology Assessment (iMTA) at ÌÇÐÄÖ±²¥. From 1996 to 1999 she held a Pfizer Health Economics Fellowship and in 2001 she obtained her PhD degree at the ÌÇÐÄÖ±²¥. Her research focuses on modelling studies and methods for dealing with uncertainty in economic evaluations. Together with Ben van Hout, Maiwenn developed the cost-effectiveness acceptability curve, now widely used as a method to describe uncertainty around ICERs. Her most current research focuses on methods for censored data, including applications in the area of mental health care, and budget allocation models. The latter topic involves both theoretical models and a survey into the decision makers' view on health care objectives and budget constraints.

Erasmus School of Health Policy & Management

Associate professor | Health Technology Assessment (HTA)
Email
al@eshpm.eur.nl

More information

Work

  • Isaac Corro Ramos, Venetia Qendri & Maiwenn Al (2024) - - BMC Medical Research Methodology, 24 (1) - doi: -
  • Isaac Corro Ramos, Talitha L. Feenstra, Salah Ghabri & Maiwenn Al (2024) - - PharmacoEconomics, 42 (7), 715-719 - doi: -
  • Katharina Abraham, Tim Andre Kanters, Adrian Stuart Wagg, Nicole Huige, Edward Hutt & Maiwenn Johanna Al (2024) - - PLoS ONE, 19 (1 January) - doi: -
  • Amber Werbrouck, Esther de Bekker-Grob, Maiwenn Al, Koen Putman & Ruben Willems (2024) - - Expert Review of Pharmacoeconomics and Outcomes Research, 24 (4), 551-557 - doi: -
  • Philip Klein, Hedwig Blommestein, Maiwenn Al, Benedetta Pongiglione, Aleksandra Torbica & Saskia de Groot (2022) - - Health Economics (United Kingdom), 31 (S1), 10-24 - doi: -
  • Fernando Albuquerque de Almeida, Isaac Corro Ramos, Maiwenn Al & Maureen van Molken (2022) - - JMIR Cardio, 6 (2) - doi: -
  • Marscha S. Holleman, Simone A. Huygens, Maiwenn J. Al, Malou C.P. Kuppen, Hans M. Westgeest, Alfonsus C.M. van den Bergh, Andries M. Bergman, Alfonsus J.M. van den Eertwegh, Mathijs P. Hendriks, Menuhin I. Lampe, Niven Mehra, Reindert J.A. van Moorselaar, Inge M. van Oort, Diederik M. Somford, Ronald de Wit, Agnes J. van de Wouw, Winald R. Gerritsen & Carin A.Uyl de Groot (2022) - - Drugs - Real World Outcomes, 9 (2), 275-285 - doi: -
  • Fernando Albuquerque de Almeida, Isaac Corro Ramos, Maureen Rutten-van Mölken & Maiwenn Al (2021) - - Value in Health, 24 (10), 1435-1445 - doi: -
  • N Armstrong, Nasuh Buyukkaramikli, Hannah Penton, R Riemsma, Pim Wetzelaer, V Huertas Carrera, SL Swift, T Drachen, H Raatz, S Ryder, D Shah, T Buksnys, G Worthy, S Duffy, Maiwenn Al & J Kleijnen (2020) - - Health Technology Assessment, 51, 1-220 - doi:
  • Fernando Albuquerque de Almeida, Maiwenn Al, R Koymans, J Riistame, S Pauws & Hans Severens (2020) - - Health and Quality of Life Outcomes, 18 (1) - doi: -

      Compare @count study programme

      • @title

        • Duration: @duration
      Compare study programmes